In multivariate regression analysis, we identified size, SUVmax, CEA level, imaging features, and N1 lymph nodes metastasis as significant independent risk factors for iLSN metastasis, and AIS/MIA/LPA was identified as a significant independent protective factor against iLSN metastasis (Table 4). This evidence concerns the gene CEACAM5 and androgen insensitivity syndrome.